Abstract
The new International Staging System should be reported in all future studies of multiple myeloma. However, the system fails to account for recent research findings pertaining to mechanisms of disease progression. This review describes development of the International Staging System and details prognostic factors that may further our understanding of the biology of multiple myeloma.
Original language | English (US) |
---|---|
Pages (from-to) | 458-468 |
Number of pages | 11 |
Journal | Leukemia and Lymphoma |
Volume | 48 |
Issue number | 3 |
DOIs | |
State | Published - Mar 2007 |
Keywords
- Gene expression profiling
- Genetics
- Imaging
- International Staging System
- Myeloma
- Prognosis
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research